Prednisone5-alpha Reductase InhibitorsAzasteroidsCholestenone 5 alpha-ReductaseProstatic HyperplasiaVincristine3-Oxo-5-alpha-Steroid 4-DehydrogenaseAlopeciaDihydrotestosteroneEnzyme InhibitorsProstatic NeoplasmsUrinary RetentionCyclophosphamideProstatePregnanoloneGlucocorticoidsDoxorubicinProstate-Specific AntigenProcarbazineAntineoplastic Combined Chemotherapy ProtocolsFlutamideTreatment OutcomeAndrostenesOrchiectomyMechlorethamineAndrogen AntagonistsPrednisoloneAzathioprineHirsutismDrug Therapy, CombinationImmunosuppressive AgentsHyaenidaeDrug Administration ScheduleUrodynamicsTestosteroneMelphalanDoxazosinMitoxantroneAntibodies, Monoclonal, Murine-DerivedAnti-Inflammatory AgentsTosyl CompoundsBleomycinMethotrexateFollow-Up StudiesColor TherapyRemission InductionChlorambucilLymphoma, Non-HodgkinDouble-Blind MethodHandling (Psychology)PregnatrienesPriapismCyclosporineL-Amino Acid OxidaseHodgkin DiseaseUrinationLymphoma, Large B-Cell, DiffuseMycophenolic AcidAndrogensProstatectomyReceptors, AndrogenTime FactorsAnticarcinogenic AgentsConvulsantsAntineoplastic Agents, HormonalDose-Response Relationship, DrugVinblastineAnilidesAdrenergic alpha-AntagonistsAsparaginaseAdrenal Cortex HormonesBiopsyFadrozoleAdministration, OralThalidomideUrinary Bladder Neck ObstructionMultiple MyelomaCentral Serous ChorioretinopathyKidney TransplantationPrescriptionsSteroidsEtoposideSeverity of Illness IndexTabletsDigital Rectal ExaminationReceptors, Tumor Necrosis Factor, Member 25Alopecia AreataProstatitisSurvival AnalysisRetrospective StudiesBias (Epidemiology)Graft RejectionBiopsy, NeedleRecurrenceDisease-Free SurvivalErectile DysfunctionTacrolimusPentylenetetrazoleProspective StudiesSilver Staining